ConductScience.org, home

Trial · NCT01263496

Outcomes57

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Participants With Adverse Events.52 Weeks.Adverse Event Profile in the Safety Analysis SetparticipantsNUMBER
SECONDARYChange From Baseline in Glycosylated Hemoglobin (Week 12).Baseline and Week 12.Values are Summary Statistics.percentage of Glycosylated HemoglobinMEAN
SECONDARYChange From Baseline in Glycosylated Hemoglobin (Week 16).Baseline and Week 16.Values are Summary Statistics.percentage of Glycosylated HemoglobinMEAN
SECONDARYChange From Baseline in Glycosylated Hemoglobin (Week 20).Baseline and Week 20.Values are Summary Statistics.percentage of Glycosylated HemoglobinMEAN
SECONDARYChange From Baseline in Glycosylated Hemoglobin (Week 24).Baseline and Week 24.Values are Summary Statistics.percentage of Glycosylated HemoglobinMEAN
SECONDARYChange From Baseline in Glycosylated Hemoglobin (Week 28).Baseline and Week 28.Values are Summary Statistics.percentage of Glycosylated HemoglobinMEAN
SECONDARYChange From Baseline in Glycosylated Hemoglobin (Week 32).Baseline and Week 32.Values are Summary Statistics.percentage of Glycosylated HemoglobinMEAN
SECONDARYChange From Baseline in Glycosylated Hemoglobin (Week 36).Baseline and Week 36.Values are Summary Statistics.percentage of Glycosylated HemoglobinMEAN
SECONDARYChange From Baseline in Glycosylated Hemoglobin (Week 40).Baseline and Week 40.Values are Summary Statistics.percentage of Glycosylated HemoglobinMEAN
SECONDARYChange From Baseline in Glycosylated Hemoglobin (Week 44).Baseline and Week 44.Values are Summary Statistics.percentage of Glycosylated HemoglobinMEAN
SECONDARYChange From Baseline in Glycosylated Hemoglobin (Week 48).Baseline and Week 48.Values are Summary Statistics.percentage of Glycosylated HemoglobinMEAN
SECONDARYChange From Baseline in Glycosylated Hemoglobin (Week 52).Baseline and Week 52.Values are Summary Statistics.percentage of Glycosylated HemoglobinMEAN
SECONDARYChange From Baseline in Glycosylated Hemoglobin (Final Visit).Baseline and Final Visit (up to Week 52).Values are Summary Statistics.percentage of Glycosylated HemoglobinMEAN
SECONDARYChange From Baseline in Fasting Plasma Glucose (Week 12).Baseline and Week 12Values are Summary Statistics.mg/dLMEAN
SECONDARYChange From Baseline in Fasting Plasma Glucose (Week 16).Baseline and Week 16.Values are Summary Statistics.mg/dLMEAN
SECONDARYChange From Baseline in Fasting Plasma Glucose (Week 20).Baseline and Week 20.Values are Summary Statistics.mg/dLMEAN
SECONDARYChange From Baseline in Fasting Plasma Glucose (Week 24).Baseline and Week 24.Values are Summary Statistics.mg/dLMEAN
SECONDARYChange From Baseline in Fasting Plasma Glucose (Week 28).Baseline and Week 28.Values are Summary Statistics.mg/dLMEAN
SECONDARYChange From Baseline in Fasting Plasma Glucose (Week 32).Baseline and Week 32.Values are Summary Statistics.mg/dLMEAN
SECONDARYChange From Baseline in Fasting Plasma Glucose (Week 36).Baseline and Week 36.Values are Summary Statistics.mg/dLMEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01263496/outcomes